Category Archives: MS Treatment

Case-Based Approach to the Treatment and Management of Multiple Sclerosis This multiple sclerosis webcast provides viewers the tools to identify patients with clinically isolated syndrome who are at high risk to go on to develop mu... By: ClevelandClinicCME … Continue reading →

A group of women with their children outside the Four Courts last week demonstrating in support of midwife Philomena Canning who had her insurance refused by the HSE. Photograph: Cyril Byrne / The Irish Times Home birth campaigners are to protest outside the Dil this week over the treatment of independent midwife Philomena Canning. The HSE withdrew Ms Cannings professional indemnity to practice following what they described as two serious incidents. She went to the High Court last week and claimed the HSEs decision to withdraw her indemnity cover, taken earlier this month, is unlawful and has effectively shut down her practice. The HSE, which opposed the application, said it temporarily suspended her insurance cover pending an investigation into the circumstances of two home births at which Ms Canning provided midwifery services. The HSE argued that while no findings of wrongdoing had been made against Ms Canning, it had to act in the interests of public health until the investigation into the incidents had been concluded. Ms Canning said she did not accept the standard of care she provided fell below the required levels. High Court judge Mr Justice Max Barrett refused to grant Ms Canning an injunction restraining the … Continue reading →

Huntsville, AL (PRWEB) October 05, 2014 Karen Lee, President and CEO of the Elk River Treatment Program (ERTP) in North Alabama, announced that Penny Baker recently accepted a position on the ERTP clinical team. Ms. Baker joins Program Director Zachary Turner, Clinical Director Dr. Wayne Wilson, Family Services Coordinator Jane Baker and Therapist Paul Bakke. Ms. Baker is a Licensed Professional Counselor (LPC), a Licensed Professional Counselor-Supervisor (LPC-S) and a National Certified Counselor (NCC). She earned a Bachelor's Degree in Sociology from Auburn University and a Master's Degree in Professional Counseling from Liberty University. Highlights of her professional work experience include: "We are fortunate to have someone with such comprehensive education and experience to join our professional staff," Ms. Lee said. "Twenty-two years of leadership experience in adolescent and family services is impressive," Ms. Lee continued, "but just as important is the extensive list of professional affiliations, activities and recognition from her peers for her service, skills and genuine love and concern for children." When asked why rejoin adolescent treatment in a rural outdoor environment, Ms. Baker said, "After working for years in a variety of treatment settings, I felt the need to return to the most rewarding and effective … Continue reading →

Oct. 5, 2014, 11:09 p.m. AN impromptu fondle from husband Mark may have helped save Nicole Lewis life. IN THE FIGHT: Breast cancer survivor Nicole Lewis, 41, is holding a fund-raising trivia night on October 24 to support research and treatment of the disease. PICTURE: JUSTIN WHITELOCK AN impromptu fondle from husband Mark may have helped save Nicole Lewis life. A lump was discovered and a short time later Ms Lewis was diagnosed with breast cancer in February 2012. Six operations, 16 rounds of chemotherapy, and 33 radiotherapy sessions followed in what was a whirlwind 12 months for the pair who have two young children. There were two moments when I thought I wouldnt see my girls grow up when Mark found the lump and when the doctor rang me confirming the diagnosis, Ms Lewis said. At first Ms Lewis, 41, struggled to accept the disease and was full of anger. I hated everything it (cancer) had done, she said. It was only as the treatment subsided and Ms Lewis found solace in two fellow sufferers that she began to mellow and become more accepting of her situation. Ms Lewis said an information session held by the Breast Cancer Network … Continue reading →

Comments(0) Treatment for multiple sclerosis (MS) patients could be revolutionised in ground-breaking trials planned by a Cambridge scientist. Dr Su Metcalfe, a University of Cambridge senior research associate based at Addenbrookes, has won a 150,000 award which will enable her team to proceed to pre-clinical trials in Nanotechnology. The award is one of only five given out this year worldwide from major pharmaceutical company, Merck Serono, and the first to a UK scientist. The technology developed for treatment of MS - an incurable autoimmune disease that attacks the central nervous system - by Dr Metcalfe uses tiny smart nanoparticles that act as magic bullets to deliver powerful factors known to increase repair of damaged myelin. The key factor is LIF, a stem cell protein. The money from the Merck-Seronos Grants for Multiple Sclerosis International (GMSI) scheme will fund preclinical trials of Metcalfes nano-therapeutic device that taps into the bodys natural mechanisms for repair and avoids use of drugs. Nanotechnology is now recognised as a key platform for healthcare, said Dr Metcalfe. Our smart technology allows us to target delivery of molecules able to repair myelin and also reduce inflammation. By using a nanoparticle platform where the safety in humans is … Continue reading →

Considerations in the Initial Treatment Strategy for Multiple Sclerosis This MS treatment webcast reviews appropriate treatment strategies based on clinical presentations and subsequent monitoring strategies once treatment is imp... By: ClevelandClinicCME … Continue reading →

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH. Neurologists Underestimate Patient Discomfort with Discussing More Typical Symptoms Patients Most Uncomfortable Engaging in Candid Dialogue about More Private Symptoms Patients and Physicians Not Always Aligned on Most Helpful Disease Resources CAMBRIDGE, Mass. --(BUSINESS WIRE)-- 10.09.2014 -- Findings from an international survey show differences in the perceptions of people living with multiple sclerosis (MS) and neurologists when discussing MS symptoms, including those that are personal and sensitive. While the results generally suggest a positive assessment of current practice in MS, important gaps were identified that could potentially impact disease management and patient quality of life. These findings will be presented this week at the Sixth Triennial Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS) in Boston. The survey, commissioned by Biogen Idec (NASDAQ: BIIB) and conducted online by Harris Poll, was developed in partnership with the State of MS Consortium, an international steering committee of treating neurologists from five countries and representatives from patient advocacy groups. The survey involved MS patients and neurologists who treat the disease in Germany, … Continue reading →

Contact Information Available for logged-in reporters only Newswise (NEW YORK September 29, 2014) Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics subsidiary of Celgene Corporation and collaborators at several other institutions. While designed to determine safety of the treatment, early signals in the data also suggested that a preparation of cultured cells called PDA-001 may repair damaged nerve tissues in patients with MS. PDA-001 cells resemble mesenchymal, stromal stem cells found in many tissues of the body. Since the cells are expanded in cell cultures, one donor is able to supply enough cells for many patients. This is the first time placenta-derived cells have been tested as a possible therapy for multiple sclerosis, said Fred Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology at Icahn School of Medicine at Mount Sinai and the lead investigator of the study. The next step will be to study larger numbers of MS patients … Continue reading →

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics subsidiary of Celgene Corporation and collaborators at several other institutions. While designed to determine safety of the treatment, early signals in the data also suggested that a preparation of cultured cells called PDA-001 may repair damaged nerve tissues in patients with MS. PDA-001 cells resemble "mesenchymal," stromal stem cells found in connective tissue in bone marrow, but unlike their bone-marrow derived counterparts, stromal cells from the placenta are more numerous, with one donor able to supply enough cells for many patients. "This is the first time placenta-derived cells have been tested as a possible therapy for multiple sclerosis," said Fred Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology at Icahn School of Medicine at Mount Sinai and the lead investigator of the study. "The next step will be to study larger numbers of MS patients to assess efficacy of the cells, but … Continue reading →

High Court judge orders brain damaged child's life support to be turned off Judge said it was in the child's best interests for the care to be withdrawn His parents disagreed, saying no-one had right to remove 'privilege'of life Judge: 'It is their belief that given time God may work a miracle' A failure in the boy's treatment was also referred to during court hearings The parties involved in the case are unable to be identified for legal reasons By Corey Charlton for MailOnline Published: 07:27 EST, 30 September 2014 | Updated: 07:29 EST, 30 September 2014 A High Court judge today ruled that a little boy with brain damage should be taken off a life-support machine despite his parents' pleas to keep him alive. Specialists had told Ms Justice Russell that the youngster - who turned one earlier this year - had suffered irreversible brain damage and it was in the youngster's best interests for live-sustaining care to be withdrawn. However, the boy's devout Christian parents - who cannot be identified for legal reasons - disagreed. Today the youngster's father said no-one had the right to take away the 'privilege' of life from his son. In words that echoed … Continue reading →